The Finnish Gestational Diabetes Study (FinnGeDi)

FinnGeDi includes two arms: a prospective clinical, genetic case-control arm and a national register-based arm. The aim of this study is to assess the effects of maternal gestational diabetes on the health and well-being of the whole family. We focus on cardiometabolic risk factors, mental health and offspring growth and development.
FinnGeDi logo

Project information

Project duration

-

Funded by

Multiple sources

Project funder

Academy of Finland
Sigrid Jusélius Foundation
Emil Aaltonen Foundation
Juho Vainio Foundation
Foundation for Diabetes Research
Signe and Ane Gyllenberg Foundation
Yrjö Jahnsson Foundation
Novo Nordisk Foundation
Päivikki and Sakari Sohlberg Foundation
The Finnish Medical Foundation
Agence Nationale de la Recherche, Ranska
Diabetes UK, United Kingdom
Suorsa Foundation
Otto A. Malm foundation
The Finnish Foundation for Cardiovascular Research

Project coordinator

University of Oulu

Contact information

Project leader

  • Marja Vääräsmäki

Contact person

Other persons

Project description

The clinical-genetic arm includes 1146 pregnant women with gestational diabetes and 1066 controls, who gave birth in one of seven secondary or tertiary level hospitals in Finland (Oulu, Helsinki, Jyväskylä, Pori, Kajaani, Seinäjoki, and Lappeenranta) in 2009-2012, together with their children and the children’s fathers.

DNA samples were collected from all participants (mothers, fathers and children). Additionally, cord blood samples were collected from children. Parents fulfilled a questionnaire including family history, health and lifestyle-related data. Maternal and child health data were collected from hospital and welfare records. Data are supplemented through biobanks and national registers including Medical Birth Register and Care Register of Health Care maintained by THL, Medication Reimbursement Register maintained by National Social Insurance Institution and Census data obtained from Statistics Finland.

A clinical follow-up study has been initiated after 10-15 years of index pregnancy with the main objective of assessing the consequences of gestational diabetes on cardiovascular and metabolic health of the mothers, with a special focus on metabolic dysfunction-associated steatotic liver disease (MASLD). 213 women with gestational diabetes in the index pregnancy (2009-2012) and 204 women without history of gestational diabetes in the index pregnancy currently residing in Oulu region participate in the study. Clinical and anthropometric measurements, assessment of lifestyle, physical fitness and behavioral factors, oral examination, imaging studies and biochemical analyses are carried out.

The register arm includes women with singleton pregnancies who gave birth in Finland in 2009 according to Medical Birth Register and their families (children, fathers, children’s grandparents). Data is compiled by national registers e.g. Care Register of Health Care maintained by THL, Medication Reimbursement Register maintained by National Social Insurance Institution and Census data obtained from Statistics Finland.